AMD Advanced Micro Devices Inc.

AMD to Report Fiscal First Quarter 2020 Financial Results

AMD to Report Fiscal First Quarter 2020 Financial Results

SANTA CLARA, Calif., April 15, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: AMD) announced today that it will report first quarter 2020 financial results on Tuesday, April 28, 2020 after the close of market. Management will conduct a conference call to discuss these results at 5:30 p.m. ET / 2:30 p.m. PT. Interested parties are invited to listen to the webcast of the conference call via AMD’s Investor Relations website . An archive of the webcast will be available for approximately one year after the conference call.

About AMD

For 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the data center. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) , , , and  pages.

AMD, the AMD Arrow logo and the combination thereof are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

Contact

Sarah Youngbauer

AMD Communications

512-602-3028

Laura Graves

AMD Investor Relations

408-749-5467

EN
15/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Advanced Micro Devices Inc.

Pierre FerraguÊ
  • Pierre FerraguÊ

Tariffs: UK & China deals – our quick update on recent developments

The tariff situation is evolving in line with our expectations. Follow the link below for our perspective on the latest developments.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch